Autoimmune Encephalitis Misdiagnosis in Adults., PMID:36441519
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study., PMID:36526426
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder., PMID:36690455
Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis., PMID:36691800
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis., PMID:36908609
MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity., PMID:37097758
Autoimmune Encephalitis Criteria in Clinical Practice., PMID:37124463
Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria., PMID:37212351
Cerebral enhancement in MOG antibody-associated disease., PMID:37221051
Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., PMID:37336767
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review., PMID:37433584
Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease., PMID:37550073
Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome., PMID:37795104
CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity., PMID:37841252
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes., PMID:38101905
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder., PMID:38134369
Peripheral nervous system manifestations of MOG antibody associated disease., PMID:38234084
New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis., PMID:38310187
Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype., PMID:38364528
Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles., PMID:38466015
Immune Checkpoint Inhibitor-Associated Kelch-Like Protein-11 IgG Brainstem Encephalitis., PMID:38484218
Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders., PMID:38494281
Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis., PMID:38497971
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysis., PMID:38506182
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use., PMID:38696737
Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease., PMID:38710000
Frequency of Asymptomatic Optic Nerve Enhancement in 203 Patients With MOG Antibody-Associated Disease., PMID:38924706
Seizure-Related Falls and Near Falls in LGI1-IgG Autoimmune Encephalitis., PMID:38938695
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease., PMID:38964848
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network., PMID:39099240
Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseases., PMID:39114659
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms., PMID:39237493
Long-term outcomes in antibody-negative autoimmune encephalitis: a retrospective study., PMID:39278895
Comprehensive Analysis of Paraneoplastic Neurologic Syndrome and PNS-CARE Diagnostic Criteria in Clinical Practice., PMID:39321395
Pediatric MOG-Ab-Associated Encephalitis: Supporting Early Recognition and Treatment., PMID:39393046
Phenotypic and oncological insights in ANNA1 autoimmunity: Age stratification and biomarker analysis., PMID:39556523
Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder., PMID:39661938
Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria., PMID:39708293
Curriculum Innovations: A Novel Neurology Clinician-Educator Program., PMID:39748890
MOG antibody-associated disease epidemiology in Olmsted County, USA, and Martinique., PMID:39812824
Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae., PMID:39832911
Testing for myelin oligodendrocyte glycoprotein antibodies: Who, what, where, when, why, and how., PMID:39861933
Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assay., PMID:39901660
Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD., PMID:39932929
Upper motor neuron-predominant motor neuron disease: a novel immunotherapy-responsive association of GAD65 autoimmunity., PMID:39998694
Exploring autoantigens in autoimmune limbic encephalitis using phage immunoprecipitation sequencing., PMID:40133514
Ventral Subpial and Central Cord Enhancement in Spinal Neurosarcoidosis: The Reverse Trident Sign., PMID:40168633
Assessing fall risk in multiple sclerosis using patient-reported outcomes and wearable gait metrics., PMID:40292035
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., PMID:40324120
From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis., PMID:40447786
For research use only. Not for human or drug use.
